COVID-19 in Immunocompromised Cancer Patients: A Case Series and Review of the Literature

The global pandemic of the novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented newfound challenges to the oncology community regarding management of disease progression in immunocompromised and cancer patients. Further, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Raj H., Vanaparthy, Rachana, Greene, John N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482717/
https://www.ncbi.nlm.nih.gov/pubmed/34579537
http://dx.doi.org/10.1177/10732748211044361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482717/
https://www.ncbi.nlm.nih.gov/pubmed/34579537
http://dx.doi.org/10.1177/10732748211044361

Ejemplares similares